UB560
TargetsActRIIA
IndicationsObesity
ClinicalCN - PCC
TherapeuticsMetabolic & Endocrinology
ModalitiesAntibody
Exclusive Summary
- • Higher binding affinity to ActRIIA compare with LEA102.
- • Fovarable druggability.
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →